LiuLiang Qin

2.2k total citations
28 papers, 622 citations indexed

About

LiuLiang Qin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, LiuLiang Qin has authored 28 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in LiuLiang Qin's work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). LiuLiang Qin is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). LiuLiang Qin collaborates with scholars based in United States, China and India. LiuLiang Qin's co-authors include Dezheng Zhao, Huiyan Zeng, Harold F. Dvorak, Janice A. Nagy, Mien Van Hoang, Lawrence F. Brown, Xiaolian Tan, E J Manseau, Donald R. Senger and Xianghui Ren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

LiuLiang Qin

26 papers receiving 609 citations

Peers

LiuLiang Qin
Liqiong Liu China
Stephen E. Kendall United States
Man Liu China
Christopher Duntsch United States
Jack Reifert United States
Winson S. Ho United States
Tian Tian China
Usha Nagavarapu United States
Simone Weström Sweden
Lennart D. Johns United States
Liqiong Liu China
LiuLiang Qin
Citations per year, relative to LiuLiang Qin LiuLiang Qin (= 1×) peers Liqiong Liu

Countries citing papers authored by LiuLiang Qin

Since Specialization
Citations

This map shows the geographic impact of LiuLiang Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LiuLiang Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LiuLiang Qin more than expected).

Fields of papers citing papers by LiuLiang Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LiuLiang Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LiuLiang Qin. The network helps show where LiuLiang Qin may publish in the future.

Co-authorship network of co-authors of LiuLiang Qin

This figure shows the co-authorship network connecting the top 25 collaborators of LiuLiang Qin. A scholar is included among the top collaborators of LiuLiang Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LiuLiang Qin. LiuLiang Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yan, Zhen Chen, Yuting Xu, et al.. (2025). Heat shock protein A1L restricts influenza A virus by ubiquitination of NA. Journal of Virology. 99(9). e0077125–e0077125.
2.
Thomas, Joshua D., Mao Yin, Natalya D. Bodyak, et al.. (2024). Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 23(4). 541–551.
3.
Thomas, Joshua D., Mao Yin, Natalya D. Bodyak, et al.. (2022). Discovery of novel polyamide-pyrrolobenzodiazepine hybrids for antibody-drug conjugates. Bioorganic & Medicinal Chemistry Letters. 72. 128876–128876. 3 indexed citations
4.
Cetinbas, Naniye Mallı, Travis Monnell, Winnie Lee, et al.. (2020). 620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates. SHILAP Revista de lepidopterología. A373.1–A373. 3 indexed citations
5.
Chen, Chen, Yan Li, LiuLiang Qin, et al.. (2019). Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells. Microvascular Research. 128. 103934–103934. 11 indexed citations
6.
Duvall, Jeremy R., Marc Damelin, Barrett J. Nehilla, et al.. (2019). Abstract 232: An antibody-drug conjugate carrying a microtubule inhibitor and a DNA alkylator exerts both mechanisms of action on tumor cells. Cancer Research. 79(13_Supplement). 232–232. 4 indexed citations
7.
Mosher, Rebecca, Laura L. Poling, LiuLiang Qin, Natalya D. Bodyak, & Donald A. Bergstrom. (2018). Abstract B119: Relationship of NaPi2b expression and efficacy of XMT-1536, a NaPi2b targeting antibody-drug conjugate (ADC), in an unselected panel of human primary ovarian mouse xenograft models. Molecular Cancer Therapeutics. 17(1_Supplement). B119–B119. 5 indexed citations
8.
Bergstrom, Donald A., Natalya D. Bodyak, Laura L. Poling, et al.. (2017). MA09.10 A NaPi2b Antibody-Drug Conjugate Induces Durable Complete Tumor Regressions in Patient-Derived Xenograft Models of NSCLC. Journal of Thoracic Oncology. 12(1). S396–S397. 3 indexed citations
9.
Gumerov, Dmitry R., Dongmei Xiao, Joshua D. Thomas, et al.. (2016). Abstract 596: Optimization of lead antibody selection for XMT-1522, a novel, highly potent HER2-targeted antibody-drug conjugate (ADC). Cancer Research. 76(14_Supplement). 596–596. 2 indexed citations
10.
Yin, Mao, Natalya D. Bodyak, Joshua D. Thomas, et al.. (2015). A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy. Cancer Research. 75(16). 3365–3372. 73 indexed citations
11.
Bergstrom, Donald A., Natalya D. Bodyak, Peter U. Park, et al.. (2015). Abstract LB-231: A novel, highly potent HER2-targeted antibody-drug conjugate (ADC) for the treatment of low HER2-expressing tumors and combination with trastuzumab-based regimens in HER2-driven tumors. Cancer Research. 75(15_Supplement). LB–231. 12 indexed citations
12.
Niu, Gengming, LiuLiang Qin, Cheng Chang, et al.. (2014). Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4. The FASEB Journal. 29(1). 131–140. 37 indexed citations
13.
Qin, LiuLiang, Dezheng Zhao, Jianfeng Xu, et al.. (2013). The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. Blood. 121(11). 2154–2164. 81 indexed citations
14.
Liu, Xin, Dezheng Zhao, LiuLiang Qin, Jian Li, & Huiyan Zeng. (2008). Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells. Journal of Biological Chemistry. 283(49). 34159–34167. 12 indexed citations
15.
Zeng, Huiyan, LiuLiang Qin, Dezheng Zhao, et al.. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity. The Journal of Experimental Medicine. 203(3). 719–729. 133 indexed citations
16.
Qin, LiuLiang, Dezheng Zhao, Xin Liu, et al.. (2006). Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway. Molecular Cancer Research. 4(11). 811–820. 65 indexed citations
17.
Qin, LiuLiang, Huiyan Zeng, & Dezheng Zhao. (2006). Requirement of Protein Kinase D Tyrosine Phosphorylation for VEGF-A165-induced Angiogenesis through Its Interaction and Regulation of Phospholipase Cγ Phosphorylation. Journal of Biological Chemistry. 281(43). 32550–32558. 49 indexed citations
18.
Zeng, Huiyan, LiuLiang Qin, Dezheng Zhao, et al.. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity. The Journal of Cell Biology. 172(7). i15–i15. 2 indexed citations
19.
Yang, Er-Bin, LiuLiang Qin, Zhao Yin-nong, Kai Zhang, & Pierce K. H. Chow. (2003). Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma. International Journal of Molecular Medicine. 11(6). 773–8. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liqiong Liu Breakdown of academic impact, for papers by Stephen E. Kendall Breakdown of academic impact, for papers by Man Liu Breakdown of academic impact, for papers by Christopher Duntsch Breakdown of academic impact, for papers by Jack Reifert Breakdown of academic impact, for papers by Winson S. Ho Breakdown of academic impact, for papers by Tian Tian Breakdown of academic impact, for papers by Usha Nagavarapu Breakdown of academic impact, for papers by Simone Weström Breakdown of academic impact, for papers by Lennart D. Johns
Rankless by CCL
2026